Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × Thalidomide × Clear all

NCT00165230 2009-04-28

Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors

Phase 2 Completed

Neuroendocrine Tumors